Skip header and navigation

8 records – page 1 of 1.

Primary care renewal

https://policybase.cma.ca/en/permalink/policy114
Date
2003-Aug-20
Topics
Health care and patient safety
Resolution
GC03-27
That Canadian Medical Association encourage proper evaluation of primary care renewal to ensure that the renewal is improving access and health care.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Aug-20
Topics
Health care and patient safety
Resolution
GC03-27
That Canadian Medical Association encourage proper evaluation of primary care renewal to ensure that the renewal is improving access and health care.
Less detail

Smoking cessation in hospitals

https://policybase.cma.ca/en/permalink/policy129
Date
2003-Aug-20
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC03-31
That Canadian Medical Association call upon the provincial and territorial governments to provide resources for every hospital to offer smoking cessation, counseling support including medication to every smoking patient in hospital and as needed after discharge.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
2003-Aug-20
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC03-31
That Canadian Medical Association call upon the provincial and territorial governments to provide resources for every hospital to offer smoking cessation, counseling support including medication to every smoking patient in hospital and as needed after discharge.
Less detail

Safety of genetically modified organisms

https://policybase.cma.ca/en/permalink/policy378
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
GC99-80
That the Canadian Medical Association ask Health Canada to ensure it obtains sound evidence of the safety of genetically modified organisms before they are authorized by Agriculture and Agri-Food Canada.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
GC99-80
That the Canadian Medical Association ask Health Canada to ensure it obtains sound evidence of the safety of genetically modified organisms before they are authorized by Agriculture and Agri-Food Canada.
Less detail

Regulations for genetically modified organisms

https://policybase.cma.ca/en/permalink/policy380
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
GC99-82
That the Canadian Medical Association urge the federal government to act quickly to adopt regulations controlling the development, testing and commercialization of genetically modified organisms.
Policy Type
Policy resolution
Last Reviewed
2020-Feb-29
Date
1999-Aug-25
Topics
Health care and patient safety
Resolution
GC99-82
That the Canadian Medical Association urge the federal government to act quickly to adopt regulations controlling the development, testing and commercialization of genetically modified organisms.
Less detail

Child restraint systems

https://policybase.cma.ca/en/permalink/policy734
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
GC91-30
That the Canadian Medical Association actively promote to all levels of government concerns regarding child safety, particularly in relation to the requirement for child restraint safety systems in all types of motor vehicles in which children routinely travel.
Policy Type
Policy resolution
Last Reviewed
2016-May-20
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
GC91-30
That the Canadian Medical Association actively promote to all levels of government concerns regarding child safety, particularly in relation to the requirement for child restraint safety systems in all types of motor vehicles in which children routinely travel.
Less detail

Smoking and radon

https://policybase.cma.ca/en/permalink/policy735
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
GC91-33
The Canadian Medical Association recognizes that radon levels greater than 150 Bq/m3 are hazardous and recommends that Health Canada advise Canadians concerning this risk, make recommendations for measuring and reducing radon levels where appropriate, and remind Canadians that smoking increases a person's risk of lung cancer due to radon exposure.
Policy Type
Policy resolution
Last Reviewed
2016-May-20
Date
1991-Aug-15
Topics
Health care and patient safety
Resolution
GC91-33
The Canadian Medical Association recognizes that radon levels greater than 150 Bq/m3 are hazardous and recommends that Health Canada advise Canadians concerning this risk, make recommendations for measuring and reducing radon levels where appropriate, and remind Canadians that smoking increases a person's risk of lung cancer due to radon exposure.
Less detail

Adverse reactions between alcohol and drug products

https://policybase.cma.ca/en/permalink/policy805
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-31
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
Less detail

Drug product substitution

https://policybase.cma.ca/en/permalink/policy806
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1987-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC87-39
The Canadian Medical Association supports the position that: 1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and 2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
Less detail

8 records – page 1 of 1.